Skip to main content
Sharon Castellino, MD, Pediatric Hematology & Oncology, Atlanta, GA

SharonMarieCastellinoMDMSc

Pediatric Hematology & Oncology Atlanta, GA

Pediatric Hematologic Oncology

Professor of Pediatrics, Emory University School of Medicine Director, Leukemia/Lymphoma Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta

Dr. Castellino is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Castellino's full profile

Already have an account?

  • Office

    5461 Meridian Mark Rd
    Ste 400
    Atlanta, GA 30342
    Phone+1 404-785-1112
    Fax+1 404-785-3600

Education & Training

  • Wake Forest University
    Wake Forest UniversityMSc, Health Outcomes, 2005 - 2008
  • Duke University Hospital
    Duke University HospitalFellowship, Pediatric Hematology/Oncology, 1995 - 1998
  • Duke University Hospital
    Duke University HospitalResidency, Pediatrics, 1994 - 1995
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterInternship, Pediatrics, 1992 - 1994
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1992
  • Mount Holyoke College
    Mount Holyoke CollegeBA, Biochemistry, Magna Cum Laude, 1984 - 1988

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2015 - 2026
  • NC State Medical License
    NC State Medical License 1994 - 2025
  • TN State Medical License
    TN State Medical License 1998 - 2005
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2010-2014
  • Clinician Investigator Award Wake Forest School of Medicine, 2013
  • America's Top Doctors for Cancer Castle Connolly, 2009-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Incidence and Outcomes of Lymphoid Malignancies in Adolescent and Young Adult Patients in the United States  
    Sharon Castellino, Frank G Keller, Christopher R Flowers, British Journal of Haematology
  • Occult GI Bleeding in a 1 yo Pediatric Cancer Survivor  
    Grimes K, Kratzer T, Russo K, Bourland D, Castellino SM, J Pediatr Gastroenerol Nutr., 1/1/2014
  • Hepato-Biliary Late Effects in Survivors of Childhood and Adolescent Cancer - A Report from the Children’s Oncology Group  
    Castellino SM, Muir A, Shah A, Shope S, McMullen K, Ruble K, Barber A, Davidoff A, Hudson MM, Pediatr Blood Cancer, 1/1/2010
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Intensive therapy free survival (ITFS) for early-stage Hodgkin lymphoma (cHL) including chemotherapy and radiation therapy (IFRT) for recurrence after chemotherapy al...
    Keller F, Castellino SM et al., Childhood, Adolescent and Young Adult Hodgkin Lymphoma, 2nd International Symposium, Berlin, Germany, 1/7/2014
  • Longitudinal Evaluation of Health Status in Aging Pediatric Hodgkin Lymphoma Survivors: Report from the Childhood Cancer Survivor Study.
    Effinger K, Leisenring W, Oeffinger KC, Hudson MM, Ness KK, Marina N, Castellino SM Stovall M, Armstrong GT, Robison LL, Sainani K, Whittemore AS, International Symposium Pediatric HL, Childhood, Adolescent and Young Adult Hodgkin Lymphoma, 2nd International Symposium, Berlin, Germany, 1/7/2014
  • Outcomes and Patterns of Failure in Children/Adolescents with low risk Hodgkin Lymphoma (HL) who are FDG-PET (PET3) positive after AVPC therapy International Symposium...
    Castellino SM et. al., Childhood, Adolescent and Young Adult Hodgkin Lymphoma, 2nd International Symposium, Berlin, Germany, 1/7/2014
  • Join now to see all

Lectures

  • Performance of FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric hodgkin lymphoma (HL) patients. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Proof-of-Paradigm of Cost-Effectiveness Analysis Within a Therapeutic Clinical Trial 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
  • Immune Modulation in Pediatric Lymphoma 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
  • Join now to see all

Press Mentions

  • Immunotherapy Breakthrough: 92% Survival for Hodgkin Lymphoma Patients
    Immunotherapy Breakthrough: 92% Survival for Hodgkin Lymphoma PatientsOctober 18th, 2024
  • Immunotherapy Extends Survival in Advanced Hodgkin Lymphoma
    Immunotherapy Extends Survival in Advanced Hodgkin LymphomaOctober 18th, 2024
  • Breakthrough Clinical Trial Reveals Better Treatment for Advanced Classic Hodgkin Lymphoma
    Breakthrough Clinical Trial Reveals Better Treatment for Advanced Classic Hodgkin LymphomaOctober 17th, 2024
  • Join now to see all

Professional Memberships